Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001437749-24-029996
Filing Date
2024-09-25
Accepted
2024-09-25 17:17:41
Documents
8
Period of Report
2024-11-22

Document Format Files

Seq Description Document Type Size
1 FORM PREM14A nby20240924_prem14a.htm PREM14A 1498665
2 EXHIBIT FILING FEES ex_726782.htm EX-FILING FEES 21218
3 a01.jpg GRAPHIC 161692
4 a02.jpg GRAPHIC 150741
5 b01.jpg GRAPHIC 13966
6 b02.jpg GRAPHIC 11083
7 b03.jpg GRAPHIC 10098
8 logo.jpg GRAPHIC 3886
  Complete submission text file 0001437749-24-029996.txt   2005285
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-33678 | Film No.: 241325455
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)